Skip to main content
Midas Edge

TEVA PHARMACEUTICAL INDUSTRIES LTD

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

TEVA$42.40-1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Legal Proceedings

ITEM 1.LEGAL PROCEEDINGS

We are subject to various litigation and other legal proceedings. For a discussion on our Commitments and Contingencies see note 10 to our consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form

10-Q.

For a discussion of additional legal proceedings, please refer to our Form

10-Q

for the period ended March 31, 2025, filed with the SEC on May 7, 2025.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.